Literature DB >> 31407091

An Exploratory Analysis of Fecal Immunochemical Test Performance for Colorectal Cancer Screening in Nigeria.

Gregory C Knapp1, Avinash Sharma2, Bolatito Olopade3, Olusegun I Alatise4, Olalekan Olasehinde4, Olujide O Arije5, Philip E Castle6, T Peter Kingham2.   

Abstract

INTRODUCTION: The fecal immunochemical test (FIT) for hemoglobin is recommended for colorectal cancer (CRC) screening in resource-limited environments. However, there are several unique variables that may alter FIT performance in this setting, including endemic intestinal parasites and high ambient temperature. This prospective study evaluated the performance of FIT in asymptomatic, average-risk individuals of screening age in rural Nigeria.
METHODS: Three hundred and twenty-four community volunteers completed a questionnaire and provided stool specimens for parasitology and microbiome analysis. Specimens were frozen and stored at -80 °C. Of 324 subjects, 139 met criteria for average-risk CRC screening and had a stool sample for analysis. These were thawed and tested with a qualitative FIT. Specimens positive for occult blood were retested every two days to evaluate the impact of time and temperature on test performance.
RESULTS: Of 139 individuals, 69 (49.6%) were positive for intestinal parasites and 10 (7.2%) were positive for occult blood. The most common pathogen was Cryptosporidium (40.6%). Among patients with intestinal parasites, 10.1% (7/69) had a positive FIT. Only 4.3% (3/70) of patients without parasites had a positive FIT (p = 0.208). On bivariate analysis, sociodemographic variables were not associated with a positive FIT result. Thirty percent (3/10) of the FIT-positive specimens became FIT-negative with routine storage.
CONCLUSION: Although a positive FIT result was more common in those with parasitic infection, the relationship was not significant in this small cohort. The impact of high ambient temperature on test positivity may necessitate shorter processing time guidelines for equatorial countries. Additional prospective studies are needed to validate FIT performance in Nigeria.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31407091     DOI: 10.1007/s00268-019-05100-0

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  37 in total

1.  Are fecal immunochemical test characteristics influenced by sample return time? A population-based colorectal cancer screening trial.

Authors:  Aafke H C van Roon; Lieke Hol; Anneke J van Vuuren; Jan Francke; Martine Ouwendijk; Angela Heijens; Nicole Nagtzaam; Jacqueline C I Y Reijerink; Alexandra C M van der Togt; Marjolein van Ballegooijen; Ernst J Kuipers; Monique E van Leerdam
Journal:  Am J Gastroenterol       Date:  2011-11-22       Impact factor: 10.864

2.  A comparison of colorectal cancer in Nigerian and North American patients: is the cancer biology different?

Authors:  Saurabh Saluja; Olusegun I Alatise; Adisa Adewale; Justine Misholy; Joanne Chou; Mithat Gonen; Martin Weiser; T Peter Kingham
Journal:  Surgery       Date:  2014-06-19       Impact factor: 3.982

3.  A vision for improved cancer screening in Nigeria.

Authors:  Foluso Ishola; Oluwatosin Omole
Journal:  Lancet Glob Health       Date:  2016-06       Impact factor: 26.763

4.  Epidemiological study of the association between malaria and helminth infections in Nigeria.

Authors:  Akinwale Michael Efunshile; Temitope Olawale; Christen Rune Stensvold; Jørgen A L Kurtzhals; Brigitte König
Journal:  Am J Trop Med Hyg       Date:  2015-01-26       Impact factor: 2.345

5.  Fresh vs Frozen Samples and Ambient Temperature Have Little Effect on Detection of Colorectal Cancer or Adenomas by a Fecal Immunochemical Test in a Colorectal Cancer Screening Cohort in Germany.

Authors:  Hongda Chen; Simone Werner; Hermann Brenner
Journal:  Clin Gastroenterol Hepatol       Date:  2016-10-26       Impact factor: 11.382

Review 6.  Cascade colorectal cancer screening guidelines: a global conceptual model.

Authors:  Sidney J Winawer; Justus Krabshuis; Rene Lambert; Michael O'Brien; Michael Fried
Journal:  J Clin Gastroenterol       Date:  2011-04       Impact factor: 3.062

7.  Epidemiological studies of intestinal helminthes and malaria among children in Lagos, Nigeria.

Authors:  G O Adeoye; C O Osayemi; O Oteniya; S O Onyemekeihia
Journal:  Pak J Biol Sci       Date:  2007-07-01

8.  Mass screening for colorectal cancer is not justified in most developing countries.

Authors:  René Lambert; Catherine Sauvaget; Rengaswamy Sankaranarayanan
Journal:  Int J Cancer       Date:  2009-07-15       Impact factor: 7.396

9.  A symptom-based model to predict colorectal cancer in low-resource countries: Results from a prospective study of patients at high risk for colorectal cancer.

Authors:  Olusegun Isaac Alatise; Omobolaji O Ayandipo; Ademola Adeyeye; Ken Seier; Akinwunmi O Komolafe; Matthew O Bojuwoye; Oludapo O Afuwape; Ann Zauber; Adeleye Omisore; Samuel Olatoke; Adegboyega Akere; Olusola Famurewa; Mithat Gonen; David O Irabor; T Peter Kingham
Journal:  Cancer       Date:  2018-04-12       Impact factor: 6.860

Review 10.  Emergence of Colorectal Cancer in West Africa: Accepting the Inevitable.

Authors:  David O Irabor
Journal:  Niger Med J       Date:  2017 May-Jun
View more
  2 in total

1.  Feasibility and performance of the fecal immunochemical test (FIT) for average-risk colorectal cancer screening in Nigeria.

Authors:  Gregory C Knapp; Olusegun Alatise; Bolatito Olopade; Marguerite Samson; Olalekan Olasehinde; Funmilola Wuraola; Oluwole O Odujoko; Akinwunmi O Komolafe; Olujide O Arije; Philip E Castle; J Joshua Smith; Martin R Weiser; T Peter Kingham
Journal:  PLoS One       Date:  2021-01-12       Impact factor: 3.240

Review 2.  Artificial intelligence and machine learning for early detection and diagnosis of colorectal cancer in sub-Saharan Africa.

Authors:  Akbar K Waljee; Eileen M Weinheimer-Haus; Amina Abubakar; Anthony K Ngugi; Geoffrey H Siwo; Gifty Kwakye; Amit G Singal; Arvind Rao; Sameer D Saini; Andrew J Read; Jessica A Baker; Ulysses Balis; Christopher K Opio; Ji Zhu; Mansoor N Saleh
Journal:  Gut       Date:  2022-04-13       Impact factor: 31.793

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.